Thiel Backs Psychedelic-Drug Startup in Latest Funding Round

April 23, 2020 Articles 7:21 pm

Billionaire investor Peter Thiel made his first investment in ATAI Life Sciences, a German startup that’s looking into ways of using magic mushrooms and other psychedelics to treat mental-health disorders.

 

JOIN THE ATAI #INSIGHTNETWORK

Receive the latest news on ATAI and innovations in the space.

Email
submit